GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock

Francisco Partners, a prominent investor in GoodRx Holdings, Inc. (NASDAQ:GDRX), recently disposed of a substantial $5.48 million worth of Class A Common Stock over several days in late August 2026. The sales occurred through two investment entities, Francisco Partners IV, L.P., and Francisco Partners IV-A, L.P., which together sold a total of 1,034,472 shares.

The transactions took place at a weighted average price of $3.462 per share, with individual shares being sold between $3.425 and $3.50 per share. On August 25, 2026, the investors sold an additional 127,273 shares at a slightly lower average price of $3.4449 per share. The following day, August 26, 2026, the investors conducted their largest single transaction, selling 423,688 shares at $3.5125 per share.

These sales marked a significant reduction in Francisco Partners' ownership stake in GoodRx, as the company's shares had surged by 95% over the previous six months, currently trading at $3.65 with a market capitalization of $1.25 billion. Despite the significant reduction in ownership, GoodRx Holdings reported strong second-quarter results, surpassing revenue expectations and raising its full-year 2026 outlook.